BioCorRx Inc.
General ticker "BICX" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $5.7M (TTM average)
BioCorRx Inc. follows the US Stock Market performance with the rate: 12.7%.
Estimated limits based on current volatility of 1.7%: low 0.33$, high 0.35$
Factors to consider:
- Total employees count: 2 as of 2009
- Top business risk factors: Economic downturns and volatility, Significant losses, Management dependency, Need for additional capital, Labor/talent shortage/retention
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.20$, 0.72$]
- 2025-12-31 to 2026-12-31 estimated range: [0.16$, 0.58$]
Financial Metrics affecting the BICX estimates:
- Positive: with PPE of -0.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -26.04 <= 0.33
- Positive: -8.75 < Industry operating profit margin (median), % of -3.16
- Positive: Inventory ratio change, % of -88.07 <= -0.75
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Shareholder equity ratio, % of -3140.48 <= 18.93
Short-term BICX quotes
Long-term BICX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.21MM | $0.09MM | $0.01MM |
| Operating Expenses | $4.91MM | $3.88MM | $5.13MM |
| Operating Income | $-4.70MM | $-3.79MM | $-5.12MM |
| Non-Operating Income | $0.32MM | $0.02MM | $-0.09MM |
| Interest Expense | $0.15MM | $0.19MM | $1.53MM |
| R&D Expense | $1.46MM | $0.89MM | $1.48MM |
| Income(Loss) | $-4.38MM | $-3.77MM | $-5.21MM |
| Profit(Loss)* | $-4.37MM | $-3.77MM | $-5.11MM |
| Stockholders Equity | $-8.20MM | $-9.82MM | $-12.12MM |
| Assets | $0.77MM | $0.39MM | $0.39MM |
| Operating Cash Flow | $-2.04MM | $-1.85MM | $-1.10MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $2.02MM | $1.85MM | $1.12MM |
| Earnings Per Share** | $-0.61 | $-0.45 | $-0.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.